References
- Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;15:54-61
- Teles AG, Carreira M, Alarcão V, et al. Prevalence, severity, and risk factors for erectile dysfunction in a representative sample of 3,548 Portuguese men aged 40 to 69 years attending primary healthcare centers: results of the Portuguese erectile dysfunction study. J Sex Med 2008;5:1317-24
- Ahn TY, Park JK, Lee SW, et al. Prevalence and risk factors for erectile dysfunction in Korean men: results of an epidemiological study. J Sex Med 2007;4:1269-76
- Aytac IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999;84:50-6
- Eardley I, Gentile V, Austoni E, et al. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction. BJU Int 2004;94:871-7
- Montorsi F, Hellstrom WJ, Valiquette L, et al. Vardenafil provides reliable efficacy over time in men with erectile dysfunction. Urology 2004;64:1187-95
- Valiquette L, Montorsi F, Auerbach S; Vardenafil Study Group. First-dose success with vardenafil in men with erectile dysfunction and associated comorbidities: RELY-I. Int J Clin Pract 2006;60:1378-85
- Chen KK, Paick JS, Ishii N; Vardenafil Study Group. The efficacy and safety of vardenafil in East Asian men with erectile dysfunction. J Sex Med 2007;4:753-61
- Shabsigh R, Duval S, Shah M, et al. Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data. Curr Med Res Opin 2007;23:2453-60
- Rubio-Aurioles E, Casabé A, Torres LO, et al. Efficacy and safety of tadalafil in the treatment of Latin American men with erectile dysfunction: results of integrated analyses. J Sex Med 2008;5:1965-76
- Carvalheira AA, Pereira NM, Maroco J, Forjaz V. Dropout in the treatment of erectile dysfunction with PDE5: a study on predictors and a qualitative analysis of reasons for discontinuation. J Sex Med 2012;9:2361-9
- Turner LA, Althof SE, Levine SB, et al. Treating erectile dysfunction with external vacuum devices: impact upon sexual, psychological and marital functioning. J Urol 1990;144:79-82
- Derouet H, Caspari D, Rohde V, et al. Treatment of erectile dysfunction with external vacuum devices. Andrologia 1999;31(Suppl 1):89-94
- Prabhu V, Alukal JP, Laze J, et al. Long-term satisfaction and predictors of use of intracorporeal injections for post-prostatectomy erectile dysfunction. J Urol 2013;189:238-42
- Coombs PG, Heck M, Guhring P, et al. A review of outcomes of an intracavernosal injection therapy programme. BJU Int 2012;110:1787-91
- Mydlo JH, Volpe MA, MacChia RJ. Results from different patient populations using combined therapy with alprostadil and sildenafil: predictors of satisfaction. BJU Int 2000;86:469-73
- Salonia A, Gallina A, Zanni G, et al. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008;53:564-70
- Stephenson RA, Mori M, Hsieh Y, et al. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the surveillance, epidemiology, and end results prostate cancer outcomes study. J Urol 2005;174:646-50
- Mulhall JP, Ahmed A, Branch J, Parker M. Serial assessment of efficacy and satisfaction profiles following penile prosthesis surgery. J Urol 2003;169:1429-33
- Rajpurkar A, Dhabuwala CB. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice. J Urol 2003;170:159-63
- Bernal RM, Henry GD. Contemporary patient satisfaction rates for three-piece inflatable penile prostheses. Adv Uro 2012;2012:1-5
- Salonia A, Ferrari M, Sacca A, et al. Delay in seeking medical help in patients with new-onset erectile dysfunction remained high over and despite the PDE5 era – an ecological study. J Sex Med 2012;9:3239-46
- Menard J, Tremeaux JC, Faix A, et al. Erectile function and sexual satisfaction before and after penile prosthesis implantation in radical prostatectomy patients: a comparison with patients with vasculogenic erectile dysfunction. J Sex Med 2011;8:3479-86
- Chronic Conditions Data Warehouse. CMS Chronic Condition Data Warehouse Condition Categories. Available at: http://www.ccwdata.org/cs/groups/public/documents/document/ccw_conditioncategories.pdf [Last accessed 22 March 2013]
- Conrad P, Leiter V. From Lydia Pinkham to Queen Levitra: direct-to-consumer advertising and medicalisation. Sociol Health Illn 2008;30:825-38
- Segal R, Burnett AL. Erectile preservation following radical prostatectomy. Ther Adv Urol 2011;3:35-46
- Sun P, Deftel A, Swindle R, et al. The costs of caring for erectile dysfunction in a managed care setting: evidence from a large national claims database. J Urol 2005;174:1948-52
- Hwang TI, Yang CR, Ho WL, Chu HW. Histopathological change of corpora cavernosa after long-term intracavernous injection. Eur Urol 1991;20:301-6
- Villarreal HG, Jones L. Outcomes of and satisfaction with the inflatable penile prosthesis in the elderly male. Adv Urol 2012;2012:240963
- Wiser H, Kottwitz M, Wilson S, Kohler T. Interesting trends in penile prosthesis usage. Presented at the 2013 Annual Meeting of the American Urological Association, 7 May 2013, San Diego, California, USA